Videos

Brittany Craiglow, MD, and Angela J Lamb, MD, discuss the varying presentation of atopic dermatitis (AD) among different skin types and skin color, as well as the challenges in gauging disease severity.

Robert L. Findling, MD, MBA, and Timothy Wilens, MD, consider the dosing and adherence challenges that arise in pediatric ADHD, as well as the potential benefits and damages of patients taking a break from treatment.

Experts in psychiatry discuss strategies for titrating to optimal doses for patients with pediatric ADHD.

Steven Selbst, MD, pediatric emergency medicine physician at Nemours Children's Health, discusses the surge of RSV cases and hospitalizations this season.

Robert L. Findling, MD, MBA, and Timothy Wilens, MD, provide an overview of available treatment options for patients with pediatric ADHD.

Experts in psychiatry review the differences between pharmacological therapy and nonpharmacological therapy as well as the criteria to start a patient on medication.

Robert L. Findling, MD, MBA, and Timothy Wilens, MD, share their thoughts on treatment considerations with the patient’s family in pediatric ADHD.

Experts in psychiatry discuss the impact of childhood ADHD on self-esteem, at home, and academically.

Robert L. Findling, MD, MBA, and Timothy Wilens, MD, review specific risk factors of pediatric ADHD, focusing on family history.

Robert L. Findling, MD, MBA, and Timothy Wilens, MD, discuss the prevalence of pediatric ADHD and how diagnosis has spiked in recent years.

Dr Elaine M. Apperson shares diabetes prevention strategies and mitigating disease complications in the pediatric population as well as advice for health care practitioners managing the disease.

Elaine M. Apperson, MD, addresses early intervention and technologies for monitoring type 1 diabetes for disease management.

An expert pediatric endocrinologist discusses raising awareness among pediatricians about type 1 diabetes.

Dr Elaine M. Apperson provides insight on when to refer patients with type 1 diabetes to pediatric endocrinology and comments on offering sibling antibody screening.

Lisa Hunter Romanelli, PhD, CEO of The REACH Institute, discusses how the mental health crisis in children has been addressed in the year since the crisis was declared by the American Academy of Pediatrics.

Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, sits down to discuss the rising threat of a "triple epidemic" consisting of influenza, COVID-19, and RSV in children.

Wendy Chung, MD, outlines the goals of the GUARDIAN study and how whole genome sequencing can improve screening in newborns,

Elaine M. Apperson, MD, reviews screening guidelines for the management of type 1 diabetes.

An expert pediatric endocrinologist addresses awareness of family history of type 1 diabetes as well as differentiating within type 1 and type 2 disease.

Kai Ling Kong, PhD, MS, discusses the results of a recent study revealing that music intervention can be used to prevent obesity in children.

Dr Elaine M. Apperson defines each stage of type 1 diabetes and how progression may present in pediatric patients.

Elaine M. Apperson, MD, reviews the prevalence and risk factors in the pediatric population for type 1 diabetes.

Dr. Hyams, MD, discusses functional constipation in children and how positive results from a phase 3 trial on linaclotide will change treatment.

Natasha Sriraman, MD, general academic pediatrician, discusses the American Academy of Pediatrics conference that took place from October 7, 2022, to October 11, 2022.

Sema4|GeneDx has announced its partnership in the GUARDIAN study, a collaboration for screening newborns through whole genome sequencing.

Devyani Chowdhury, MD, discusses her session on syncope in young children at the 2022 AAP National Conference & Exhibition.

Russell Libby, MD, FAAP, one of the Editorial Advisory Board members for Contemporary Pediatrics®, discusses why he is excited about going to the American Academy of Pediatrics National Conference & Exhibition in Anaheim, California, October 7-11.

Mimi Winsberg, MD, chief medical officer at Brightside Health, discusses new data on how telehealth intervention is efficient at reducing suicidal ideation when implemented correctly.

Gregg Sylvester, MD, MPH, chief health officer at CSL Seqirus, discusses an FDA-approved cell-based flu vaccine for children as young as 6 months, trends in childhood vaccination rates, and how to prepare for the upcoming flu season.

Ian McGovern, Epidemiologist, Senior Manager at CSL Seqirus, discusses new data on influenza gathered in a recent study, and how influenza rates are expecting to rise in the 2022 to 2023 flu season.